arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Nuwellis, Inc.

NUWE
$1.50 ▼ -0.14 (-8.26%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
62 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
14
Health
Poor
Bearish
auto_awesome

Analytical Summary

Nuwellis, Inc. faces fundamental challenges with weakness in Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $3.1M
Dividend Yield
Revenue Growth 26.2%
Op. Margin -190.1%
ROIC -171.7%
FCF / Share $-1.51
Trailing P/E
Price / Book 1.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

62-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.40M
↑ +26.2%
Net Income Profit after all expenses
$-4.54M
↓ -50.7%
Operating Margin Operating profit as % of sales
-190.1%
↓ -88.6% 1th
FCF / Share Free cash flow per share
$-1.51
↑ +93.7%
Long-Term Debt Long-term obligations
$1.97M
↓ -33.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
1
Cash Quality
45

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 62 quarters